Value Investing News

LCA-Vision (LCAV) and TLC Vision (TLCV) compete in an otherwise highly fragmented laser vision correction industry. Because the surgery is elective, expensive, and not generally covered by insurance companies, demand for the surgery is cyclical. As a result, this is a tough time for these companies, and the market has punished the stocks.

• http://barelkarsan.com/2008/11/laser-eye-surgery-too-new-to-value.html (2)